New anaylsis finds a diabetes pill, on its way toward federal approval, doubles the risks of deaths, heart attacks and strokes. Muraglitazar, to be sold under the name Pargluva for treatment of Type 2 diabetes, was endorsed by a Food and Drug Administration panel last month.

Researchers with the Cleveland Clinic analyzed the data on the drug, developed by Bristol-Myers Squibb and Merck & Co., which the FDA made public before the panel vote

A study released Sunday in the online issue of Nature Genetics reveals that a team of international researchers discover that a specific gene on chromosome 15 regulates inflammation, a finding with implications for a wide range of disorders, including cancer, cardiovascular disease, diabetes, obesity, Alzheimer's, and infections.

"Practically every common disease involves an inflammation component," says John Blangero, Ph.D., a scientist at the Southwest Foundation for Biomedical Research in San Antonio and the paper's senior author

A pilot study has found people might sleep better if they regularly eat chili. Researchers at the University of Tasmania have spent the past 18 months studying the potential health benefits of chili and its effects on sleep and diet.

Participants in the study were given 15 grams of chili each day, while others did not have any. The results were compared to see what effect it had on their health and well-being

Local representatives and senators were asked for more research funding to prevent pregnancy complications at the Women in Government's 7th annual regional conference, on September, 28.

The number of preterm birth and low birth-weight infants are the most pressing obstetrical issues today, reports Michael Paidas, M.D., associate professor and director of The Program for Thrombosis and Hemostasis in Women's Health in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine

Local representatives and senators were asked for more research funding to prevent pregnancy complications at the Women in Government's 7th annual regional conference, on September, 28.

The number of preterm birth and low birth-weight infants are the most pressing obstetrical issues today, reports Michael Paidas, M.D., associate professor and director of The Program for Thrombosis and Hemostasis in Women's Health in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine